Financial results - CLINICA NOVA SRL

Financial Summary - Clinica Nova Srl
Unique identification code: 24386791
Registration number: J40/14493/2008
Nace: 8622
Sales - Ron
419.895
Net Profit - Ron
244.144
Employee
4
The most important financial indicators for the company Clinica Nova Srl - Unique Identification Number 24386791: sales in 2023 was 419.895 euro, registering a net profit of 244.144 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Clinica Nova Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 54.594 44.589 156 21.493 0 0 0 80.422 420.401 419.895
Total Income - EUR 54.596 44.590 156 21.493 0 0 2 80.422 424.199 425.888
Total Expenses - EUR 8.564 17.299 15.602 24.733 430 0 1.982 1.900 43.538 177.954
Gross Profit/Loss - EUR 46.032 27.291 -15.446 -3.240 -430 0 -1.980 78.522 380.661 247.934
Net Profit/Loss - EUR 44.654 25.984 -15.450 -3.240 -430 0 -1.980 77.814 376.541 244.144
Employees 6 12 0 1 1 0 0 1 2 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 0.2%, from 420.401 euro in the year 2022, to 419.895 euro in 2023. The Net Profit decreased by -131.255 euro, from 376.541 euro in 2022, to 244.144 in the last year.

Check the financial reports for the company - Clinica Nova Srl

Rating financiar

Financial Rating -
Clinica Nova Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Clinica Nova Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Clinica Nova Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Clinica Nova Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Clinica Nova Srl - CUI 24386791

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 21.716 0 0 0 0 0 0 0 0 0
Current Assets 54.692 101.303 95.626 64.021 62.416 61.207 57.400 135.256 392.442 460.484
Inventories 0 0 0 105 103 101 364 0 0 0
Receivables 22.537 42.331 21.799 20.503 20.127 19.737 18.645 18.232 331.506 173.252
Cash 32.155 58.972 73.827 43.413 42.186 41.369 38.391 117.024 60.936 287.231
Shareholders Funds 59.201 85.679 79.375 63.293 61.702 60.507 57.379 133.921 385.707 254.785
Social Capital 45 45 10.065 9.895 9.713 9.525 9.344 9.137 9.166 9.138
Debts 17.207 15.624 16.251 728 715 701 21 1.334 6.735 205.698
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 460.484 euro in 2023 which includes Inventories of 0 euro, Receivables of 173.252 euro and cash availability of 287.231 euro.
The company's Equity was valued at 254.785 euro, while total Liabilities amounted to 205.698 euro. Equity decreased by -129.752 euro, from 385.707 euro in 2022, to 254.785 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Clinica Nova Srl

Comments - Clinica Nova Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.